Auditory characteristics and therapeutic effects of enzyme replacement in mouse model of the mucopolysaccharidosis (MPS) II.
about
An overview of Korean patients with mucopolysaccharidosis and collaboration through the Asia Pacific MPS Network.Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients.What have we learned from murine models of otitis media?High-dose enzyme replacement therapy attenuates cerebroventriculomegaly in a mouse model of mucopolysaccharidosis type II.
P2860
Auditory characteristics and therapeutic effects of enzyme replacement in mouse model of the mucopolysaccharidosis (MPS) II.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Auditory characteristics and t ...... ucopolysaccharidosis (MPS) II.
@en
Auditory characteristics and t ...... l of the mucopolysaccharidosis
@nl
type
label
Auditory characteristics and t ...... ucopolysaccharidosis (MPS) II.
@en
Auditory characteristics and t ...... l of the mucopolysaccharidosis
@nl
prefLabel
Auditory characteristics and t ...... ucopolysaccharidosis (MPS) II.
@en
Auditory characteristics and t ...... l of the mucopolysaccharidosis
@nl
P2093
P2860
P356
P1476
Auditory characteristics and t ...... mucopolysaccharidosis (MPS) II
@en
P2093
Chi-Hwa Kim
Dong-Kyu Jin
Il Joon Moon
Ki Ryung Kim
Moon Hee Ko
Myung-Whan Suh
Se-Hwa Kim
See Youn Kwon
P2860
P304
P356
10.1002/AJMG.A.35498
P407
P50
P577
2012-07-27T00:00:00Z